Lyons Gary A insider trades
Lyons Gary A has filed 33 Form 4s with the SEC that we hold, for Neurocrine Biosciences INC (NBIX) (Director), Travere Therapeutics, Inc. (TVTX) (Director), Eledon Pharmaceuticals, Inc. (ELDN) (Director) and Rigel Pharmaceuticals INC (RIGL) (Director), among 5 companies in all. Across all of them we count 0 purchases worth $0 and 20 sales worth $14.6M reported on Form 4. In the last 12 months: 0 purchases ($0) and 7 sales ($3.3M). The largest single trade was a sale of 15,000 shares of Neurocrine Biosciences INC worth $2.3M, dated 2025-12-03. The first filing on our record is dated 2021-10-12 and the latest 2026-08-19.
Neurocrine Biosciences INC (NBIX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-10-07 | S, sale reported on Form 4 | 5,000 | $525.3K | 2021-10-12 |
| 2022-04-25 | S, sale reported on Form 4 | 15,000 | $1.4M | 2022-04-27 |
| 2022-10-04 | S, sale reported on Form 4 | 5,000 | $552.7K | 2022-10-05 |
| 2022-10-31 | S, sale reported on Form 4 | 15,000 | $1.7M | 2022-11-02 |
| 2023-09-01 | S, sale reported on Form 4 | 5,000 | $550.3K | 2023-09-06 |
| 2023-09-12 | S, sale reported on Form 4 | 5,000 | $575.1K | 2023-09-14 |
| 2023-12-01 | S, sale reported on Form 4 | 5,000 | $583.9K | 2023-12-05 |
| 2023-12-22 | S, sale reported on Form 4 | 10,000 | $1.3M | 2023-12-27 |
| 2024-05-14 | S, sale reported on Form 4 | 12,500 | $1.7M | 2024-05-16 |
| 2024-07-16 | S, sale reported on Form 4 | 930 | $139.5K | 2024-07-18 |
| 2024-08-13 | S, sale reported on Form 4 | 11,570 | $1.7M | 2024-08-15 |
| 2025-12-03 | S, sale reported on Form 4 | 15,000 | $2.3M | 2025-12-04 |
Travere Therapeutics, Inc. (TVTX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-10-04 | S, sale reported on Form 4 | 18,821 | $285.1K | 2024-10-04 |
| 2024-10-04 | S, sale reported on Form 4 | 21,179 | $303.9K | 2024-10-04 |
| 2026-04-14 | S, sale reported on Form 4 | 8,000 | $328.6K | 2026-04-16 |
| 2026-08-17 | S, sale reported on Form 4 | 1,900 | $118.8K | 2026-08-19 |
| 2026-08-17 | S, sale reported on Form 4 | 2,600 | $165.1K | 2026-08-19 |
| 2026-08-17 | S, sale reported on Form 4 | 500 | $32.1K | 2026-08-19 |
| 2026-08-18 | S, sale reported on Form 4 | 4,100 | $259.4K | 2026-08-19 |
| 2026-08-18 | S, sale reported on Form 4 | 900 | $57.5K | 2026-08-19 |
Eledon Pharmaceuticals, Inc. (ELDN)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Rigel Pharmaceuticals INC (RIGL)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
BBI
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1123343) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms